Bovie Medical Enters Sales Partnership with ConMed

By Julie A. Vetalice

Bovie Medical entered into a global sales channel partnership agreement with CONMED for its PlazXact™ Ablator, which will be marketed as the UltrAblator Bipolar® series effective in March 2017.

The PlazXact ablator is a sterile, single-use device for the cutting, coagulating and ablation of soft tissue in arthroscopic procedures.

The agreement complements ConMed's strategy to provide a full range of competitively-priced ablator products that cover a variety of arthroscopic procedures for small and large joints.

Sources: Bovie Medical Corporation and ConMed Corporation;

Product Labels: Arthroscopy Equipment

Tags: M&A